You're reading the free version. Trader adds the live tape and alerts.
Start tracking
COGT Award Disclosure
Ferrante Karen Jean · SEC Form 4 · Filed Jul 6, 2026
Award
Calculated transaction value
$0
Ferrante Karen Jean Director
COGT
Cogent Biosciences
COGT
Transaction date
Jul 1, 2026
Public filing date
Jul 6, 2026
Filing lag
Filed 5 days later
COGT daily price context
Close on/before transaction
$38.48
Jul 1, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 627 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001193125-26-296249
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Cogent Biosciences, Inc. COGT Current | Award | Jul 1, 2026 | $0 |